COGNITION THERAPEUTICS INC (CGTX)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | Khattar Jack A. | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | Monia Brett P | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | Wallace Peggy | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | RICHSTONE ELLEN B | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | BIOS Memory SPV I, LP | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | Khattar Jack A. | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | Monia Brett P | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | Wallace Peggy | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | RICHSTONE ELLEN B | director | A | 25,000 | 0 | $0 |
| 2026-06-17 | Fletcher Aaron G.L.; BIOS Capital Management, LP; BIOS Advisors GP, LLC; Bios Equity Partners, LP; BIOS Fund I, LP; BIOS Fund II QP, LP; BIOS Memory SPV I, LP; Bios Equity Partners II, LP; BIOS Fund II, LP; BIOS Fund I QP, LP | director | A | 25,000 | 0 | $0 |
| 2026-05-01 | Doyle John Brendan | officer | F | 8,567 | 1.28 | $10,966 |
| 2026-05-01 | Doyle John Brendan | officer | F | 8,567 | 1.28 | $10,966 |
| 2026-04-16 | Doyle John Brendan | officer | P | 10,000 | 1.13 | $11,300 |
| 2026-04-16 | Ricciardi Lisa | director | P | 9,175 | 1.1 | $10,093 |
| 2026-04-16 | Caggiano Anthony | officer | P | 10,000 | 1.11 | $11,100 |
| 2026-04-16 | Doyle John Brendan | officer | P | 10,000 | 1.13 | $11,300 |
| 2026-04-16 | Ricciardi Lisa | director | P | 9,175 | 1.1 | $10,093 |
| 2026-04-16 | Caggiano Anthony | officer | P | 10,000 | 1.11 | $11,100 |
| 2026-02-15 | Ricciardi Lisa | director | F | 5,850 | 1.12 | $6,552 |
| 2026-02-15 | Doyle John Brendan | officer | F | 1,560 | 1.12 | $1,747 |
| 2026-02-15 | Caggiano Anthony | officer | F | 4,680 | 1.12 | $5,242 |
| 2026-02-15 | Ricciardi Lisa | director | F | 5,850 | 1.12 | $6,552 |
| 2026-02-15 | Doyle John Brendan | officer | F | 1,560 | 1.12 | $1,747 |
| 2026-02-15 | Caggiano Anthony | officer | F | 4,680 | 1.12 | $5,242 |
| 2026-02-04 | Ricciardi Lisa | director | F | 51,704 | 1.03 | $53,255 |
| 2026-02-04 | Doyle John Brendan | officer | F | 26,921 | 1.03 | $27,729 |
| 2026-02-04 | Caggiano Anthony | officer | F | 26,919 | 1.03 | $27,727 |
| 2026-02-04 | Ricciardi Lisa | director | F | 51,704 | 1.03 | $53,255 |
| 2026-02-04 | Doyle John Brendan | officer | F | 26,921 | 1.03 | $27,729 |
| 2026-02-04 | Caggiano Anthony | officer | F | 26,919 | 1.03 | $27,727 |
| 2026-02-03 | Ricciardi Lisa | director | F | 26,036 | 1.12 | $29,160 |
| 2026-02-03 | Ricciardi Lisa | director | A | 800,000 | 0 | $0 |
| 2026-02-03 | Doyle John Brendan | officer | A | 200,000 | 0 | $0 |
| 2026-02-03 | Caggiano Anthony | officer | F | 11,488 | 1.12 | $12,867 |
| 2026-02-03 | Caggiano Anthony | officer | A | 400,000 | 0 | $0 |
| 2026-02-03 | Ricciardi Lisa | director | A | 800,000 | 0 | $0 |
| 2026-02-03 | Ricciardi Lisa | director | F | 26,036 | 1.12 | $29,160 |
| 2026-02-03 | Doyle John Brendan | officer | A | 200,000 | 0 | $0 |
| 2026-02-03 | Caggiano Anthony | officer | A | 400,000 | 0 | $0 |
| 2026-02-03 | Caggiano Anthony | officer | F | 11,488 | 1.12 | $12,867 |
| 2025-12-18 | Ricciardi Lisa | director | F | 23,400 | 1.5 | $35,100 |
| 2025-12-18 | Ricciardi Lisa | director | A | 75,000 | 0 | $0 |
| 2025-12-18 | Caggiano Anthony | officer | F | 20,280 | 1.5 | $30,420 |
| 2025-12-18 | Caggiano Anthony | officer | A | 65,000 | 0 | $0 |
| 2025-12-18 | Doyle John Brendan | officer | F | 9,360 | 1.5 | $14,040 |
| 2025-12-18 | Doyle John Brendan | officer | A | 30,000 | 0 | $0 |
| 2025-12-18 | Ricciardi Lisa | director | A | 75,000 | 0 | $0 |
| 2025-12-18 | Ricciardi Lisa | director | F | 23,400 | 1.5 | $35,100 |
| 2025-12-18 | Caggiano Anthony | officer | A | 65,000 | 0 | $0 |
| 2025-12-18 | Caggiano Anthony | officer | F | 20,280 | 1.5 | $30,420 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.